...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New trial
Reply New Message
Back To Forum List View
Re: New trial
3
KayakerBC
May 25, 2021 10:36PM
Re: New trial
3
KOO-KOO2
May 26, 2021 09:35AM
Re: New trial
3
KayakerBC
May 26, 2021 01:25PM
Re: New trial
2
KayakerBC
May 26, 2021 02:56PM
Re: New trial
4
fuzzyjr
May 27, 2021 04:13PM
Icon president Re: New trial
4
RVXoldtimer
May 28, 2021 10:57PM

Well, yes and no. What took value away from rvx was repeated trial failure.

The spinoff of Zenith occured at the end of a trading day in 2013 and the next morning, and over the next day or two, RVX stock price dropped by the perceived value of the Zenith shares.

 

 

3 Recommendations
Icon president Re: New trial
3
RVXoldtimer
May 29, 2021 10:08AM
Re: New trial
2
fuzzyjr
May 29, 2021 10:12AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply